To refer a patient to Fox Chase Cancer Center, call 888-FOX-CHASE (888-369-2427)
To refer a patient to the Temple Lung Center, call 800-TEMPLE-MED (877-589-0013)
Featured Items |view more
Management of Early Stage Non-Small Cell Lung Cancer
This conference was presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education. It was designed as a forum for discussion of advances in technology and treatment of early ...
A More Accurate, Less Invasive Analysis for Lung Cancers: RNA Next-Generation Sequencing
Genetically targeted therapy for lung cancer can make treatment much more effective, but identifying the specific gene fusions involved in the disease remains a challenge.
Bispecifics: A Molecular Missile That Labels Cancer Cells and Kills Them
A relatively new classification of immunotherapeutic drugs is pushing the outer limits of late-line treatment, bringing new hope to patients and the cancer community. They’re bispecific antibodies.
Each year, more lung cancer patients die from their disease than prostate, breast and colon cancer patients combined, making it the leading cause of deaths worldwide.
Temple Healthy Chest Initiative: a New Approach to Lung Cancer Screening
Physicians at Temple Health have developed the Temple Healthy Chest Initiative to screen, diagnose, treat, and support patients who are at the greatest risk of developing lung cancer due to a history of smoking.
Temple – Fox Chase Thoracic Surgery
The thoracic surgery program at Temple Health provides high-quality surgical care for a wide range of conditions, from benign to thoracic malignancies in the lungs, esophagus, airways, pleura, or chest wall.
Molecular Profiling Continues to Shape the Future of Cancer Care
Unraveling the genome to reshape cancer care.
High Expectations for Adoptive Cell Therapy for Treatment of Solid Tumors
A partnership between the Fox Chase solid tumor oncologists and their colleagues in bone marrow transplantation tests the potential of adoptive cell therapies for the treatment of solid tumors.
Immunotherapy for Never Smokers with Non-Small Cell Lung Cancer
To further evaluate the use of immunotherapy for these patients with NSCLC, Treat is serving as a primary investigator in a nationwide Phase II, double-arm, randomized clinical trial of treatment-naïve never smokers without the EGFR driver ...
Pulsed Low-Dose-Rate Radiation Offers New Treatment Option for Variety of Solid Tumors
Clinicians at Fox Chase Cancer Center are exploring how an established radiation technique—pulsed low-dose-rate radiation (PLDR)—might benefit patients with a variety of solid tumors.
Temple Healthy Chest Initiative: Early Diagnosis Leads to Better Treatment Options
The Temple Healthy Chest Initiative is a comprehensive, multidisciplinary program that is designed to provide people in the Philadelphia region access to chest health screening, prevention and treatment options.
Temple Healthy Chest Initiative: Screening for Lung Cancer Can Be the Bridge to Better Care
With expanded 2021 guidelines from the U.S. Preventive Services Task Force for lung cancer screening of current and former smokers, many health care organizations are ramping up their screening efforts.
Fox Chase at Temple University Hospital Lung Cancer program Info
Specialists in the Lung Cancer Program at Temple provide advanced care for lung cancer, from detection to treatment through recovery and survivorship.
A Bold Approach to Early Lung Cancer Detection–and Action
Early, accurate detection of disease is a key factor to having better outcomes from most medical treatments. This rings especially true with lung cancer, which is the leading cause of cancer-related death in the U.S. while disproportionately ...